6.36
price up icon36.77%   1.71
after-market Handel nachbörslich: 6.00 -0.36 -5.66%
loading

Polaryx Therapeutics Inc Aktie (PLYX) Neueste Nachrichten

pulisher
Mar 12, 2026

PLYX Stock Rockets To Best Day Ever: Why Retail Traders Are Piling Into This Battered Biotech - Stocktwits

Mar 12, 2026
pulisher
Mar 12, 2026

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Biotech backs Krabbe families with research summit and Putt-Putt event - Stock Titan

Mar 12, 2026
pulisher
Mar 11, 2026

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? - Asianet Newsable

Mar 11, 2026
pulisher
Mar 11, 2026

Polaryx Therapeutics, Inc.Common Stock (Nasdaq:PLYX) Stock Quote - The Chronicle-Journal

Mar 11, 2026
pulisher
Mar 10, 2026

Polaryx Therapeutics (PLYX) Insider Trading Activity 2026 - MarketBeat

Mar 10, 2026
pulisher
Mar 01, 2026

Polaryx Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PLYX | US73110F1003 - marketscreener.com

Mar 01, 2026
pulisher
Feb 27, 2026

Polaryx commits to patients with rare pediatric lysosomal storage disorders - TipRanks

Feb 27, 2026
pulisher
Feb 27, 2026

Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History - Benzinga

Feb 27, 2026
pulisher
Feb 27, 2026

Maxim starts Polaryx at Buy, sees PLX-200 as differentiated - TipRanks

Feb 27, 2026
pulisher
Feb 27, 2026

PLYX | Polaryx Therapeutics, Inc. Common Analyst Forecasts - Quiver Quantitative

Feb 27, 2026
pulisher
Feb 27, 2026

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders - Bitget

Feb 27, 2026
pulisher
Feb 27, 2026

PLYX | Polaryx Therapeutics, Inc. Common Insider Trading - Quiver Quantitative

Feb 27, 2026
pulisher
Feb 23, 2026

Mstone Partners Healthcare Highlights Polaryx Therapeutics’ Latest Preclinical Data Shared at WORLDSymposium™ - EIN News

Feb 23, 2026
pulisher
Feb 21, 2026

Polaryx Therapeutics (PLYX) 10K Form and SEC Filings 2026 - MarketBeat

Feb 21, 2026
pulisher
Feb 21, 2026

Polaryx Therapeutics (PLYX) Stock Forecast and Price Target 2026 - MarketBeat

Feb 21, 2026
pulisher
Feb 20, 2026

Polaryx Therapeutics (PLYX) Stock Price, News & Analysis - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Top Polaryx Therapeutics (PLYX) Competitors 2026 - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Polaryx Therapeutics (PLYX) Stock Trends and Sentiment 2026 - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Insider Buying: G. Landis Acquires Shares of Polaryx Therapeutics Inc (PLYX) - GuruFocus

Feb 20, 2026
pulisher
Feb 19, 2026

PLYX Stock Price, News & Analysis - Stock Titan

Feb 19, 2026
pulisher
Feb 18, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Feb 18, 2026
pulisher
Feb 18, 2026

What's Going On With Polaryx Therapeutics Stock Wednesday? - Benzinga

Feb 18, 2026
pulisher
Feb 18, 2026

Dow Gains 100 Points; Analog Devices Posts Upbeat Q1 Earnings - Benzinga

Feb 18, 2026
pulisher
Feb 18, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 18, 2026
pulisher
Feb 18, 2026

Polaryx selects CRO for phase 2 trial of rare disease treatment - Investing.com South Africa

Feb 18, 2026
pulisher
Feb 17, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Feb 17, 2026
pulisher
Feb 17, 2026

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans - Bitget

Feb 17, 2026
pulisher
Feb 17, 2026

SMJ INTERNATIONAL HOLDINGS INC. (SMJF) Stock, Price, News, Quotes, Forecast and Insights - MSN

Feb 17, 2026
pulisher
Feb 17, 2026

Polaryx Therapeutics Surges Amid Strategic Market Moves - StocksToTrade

Feb 17, 2026
pulisher
Feb 17, 2026

Polaryx Therapeutics Sees Strategic Moves Amid Market Volatility - timothysykes.com

Feb 17, 2026
pulisher
Feb 17, 2026

Polaryx selects CRO for Soteria Phase 2 trial - TipRanks

Feb 17, 2026
pulisher
Feb 17, 2026

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial - The Manila Times

Feb 17, 2026
pulisher
Feb 17, 2026

Polaryx Therapeutics selects contract research organization for Soteria phase 2 basket trial - marketscreener.com

Feb 17, 2026
pulisher
Feb 17, 2026

Rare-disease biotech readies Phase 2 trial across four childhood disorders - Stock Titan

Feb 17, 2026
pulisher
Feb 17, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 17, 2026
pulisher
Feb 13, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

FORTUNE BRANDS INNOVATIONS, INC. (FBIN) Stock, Price, News, Quotes, Forecast and Insights - MSN

Feb 13, 2026
pulisher
Feb 12, 2026

Polaryx Therapeutics, Inc. Rings the Closing Bell - Nasdaq

Feb 12, 2026
pulisher
Feb 11, 2026

NUSCALE POWER CORPORATION (SMR) Stock, Price, News, Quotes, Forecast and Insights - MSN

Feb 11, 2026
pulisher
Feb 10, 2026

Polaryx to evaluate PLX-200 for Krabbe disease in Phase 2 trial - Investing.com South Africa

Feb 10, 2026
pulisher
Feb 10, 2026

Polaryx announces pre-clinical data related to Soteria - TipRanks

Feb 10, 2026
pulisher
Feb 10, 2026

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ - The Manila Times

Feb 10, 2026
pulisher
Feb 10, 2026

In mice with Krabbe disease, Polaryx drug restored movement, extended life - Stock Titan

Feb 10, 2026
pulisher
Feb 09, 2026

Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings - Benzinga

Feb 09, 2026
pulisher
Feb 09, 2026

Morning Market Movers: UOKA, KD, HIMS, PGY See Big Swings - RTTNews

Feb 09, 2026
pulisher
Feb 09, 2026

Strategy, Bitmine Immersion Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Feb 09, 2026
pulisher
Feb 09, 2026

Why STMicroelectronics Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 09, 2026
pulisher
Feb 06, 2026

Finance Watch: Four IPOs In One Week - Citeline News & Insights

Feb 06, 2026
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):